248 related articles for article (PubMed ID: 30947551)
1. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis.
Shoji J; Ohashi Y; Fukushima A; Miyazaki D; Uchio E; Takamura E; Fujishima H; Namba K; Kumagai N; Ebihara N; Okamoto S
Curr Eye Res; 2019 Jul; 44(7):796-805. PubMed ID: 30947551
[No Abstract] [Full Text] [Related]
2. Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus.
Hirota A; Shoji J; Inada N; Shiraki Y; Yamagami S
Cornea; 2022 Jan; 41(1):23-30. PubMed ID: 34870621
[TBL] [Abstract][Full Text] [Related]
3. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
[TBL] [Abstract][Full Text] [Related]
4. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
[TBL] [Abstract][Full Text] [Related]
5. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis.
Ohashi Y; Ebihara N; Fujishima H; Fukushima A; Kumagai N; Nakagawa Y; Namba K; Okamoto S; Shoji J; Takamura E; Hayashi K
J Ocul Pharmacol Ther; 2010 Apr; 26(2):165-74. PubMed ID: 20307214
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis.
Yazu H; Shimizu E; Aketa N; Dogru M; Okada N; Fukagawa K; Fujishima H
Ann Allergy Asthma Immunol; 2019 Apr; 122(4):387-392.e1. PubMed ID: 30639466
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement.
Fukushima A; Ohashi Y; Ebihara N; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Namba K; Fujishima H; Miyazaki D
Br J Ophthalmol; 2014 Aug; 98(8):1023-7. PubMed ID: 24695688
[TBL] [Abstract][Full Text] [Related]
8. [Follow-up study on patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment].
Harada N; Inada N; Ishimori A; Shoji J; Sawa M
Nippon Ganka Gakkai Zasshi; 2014 Apr; 118(4):378-84. PubMed ID: 24864437
[TBL] [Abstract][Full Text] [Related]
9. [Tacrolimus ointment in the management of atopic keratoconjunctivitis].
Benaim D; Tétart F; Bauvin O; Delcampe A; Joly P; Muraine M; Gueudry J
J Fr Ophtalmol; 2019 May; 42(5):435-440. PubMed ID: 30935698
[TBL] [Abstract][Full Text] [Related]
10. Atopic keratoconjunctivitis: A diagnostic dilemma-a case report.
Li A; Li S; Ruan F; Jie Y
Medicine (Baltimore); 2018 Apr; 97(16):e0372. PubMed ID: 29668589
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis.
Wan Q; Tang J; Han Y; Wang D; Ye H
Ophthalmic Res; 2018; 59(3):126-134. PubMed ID: 28803239
[TBL] [Abstract][Full Text] [Related]
12. Steroid-Sparing Effect of 0.1% Tacrolimus Eye Drop for Treatment of Shield Ulcer and Corneal Epitheliopathy in Refractory Allergic Ocular Diseases.
Miyazaki D; Fukushima A; Ohashi Y; Ebihara N; Uchio E; Okamoto S; Shoji J; Takamura E; Nakagawa Y; Namba K; Fujishima H
Ophthalmology; 2017 Mar; 124(3):287-294. PubMed ID: 28017421
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population.
Samyukta SK; Pawar N; Ravindran M; Allapitchai F; Rengappa R
J AAPOS; 2019 Feb; 23(1):36.e1-36.e5. PubMed ID: 30664932
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature.
García DP; Alperte JI; Cristóbal JA; Mateo Orobia AJ; Muro EM; Valyi Z; Del Rio BJ; Arnao MR
Cornea; 2011 Apr; 30(4):462-5. PubMed ID: 20861732
[TBL] [Abstract][Full Text] [Related]
15. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children.
Liendo VL; Vola ME; Barreiro TP; Wakamatsu TH; Gomes JÁP; Santos MSD
Arq Bras Oftalmol; 2017; 80(4):211-214. PubMed ID: 28954018
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus ointment in the management of atopic keratoconjunctivitis.
Benaim D; Tétart F; Bauvin O; Delcampe A; Joly P; Muraine M; Gueudry J
J Fr Ophtalmol; 2019 Apr; 42(4):e147-e151. PubMed ID: 30851973
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of a new therapy using rebamipide eyedrops in patients with VKC/AKC refractory to conventional anti-allergic treatments.
Ueta M; Sotozono C; Koga A; Yokoi N; Kinoshita S
Allergol Int; 2014 Mar; 63(1):75-81. PubMed ID: 24457813
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus in Corticosteroid-Refractory Vernal Keratoconjunctivitis.
Chatterjee S; Agrawal D
Cornea; 2016 Nov; 35(11):1444-1448. PubMed ID: 27310883
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of allergic conjunctival granuloma by topical tacrolimus: A clinicopathologic case report.
Foroutan A; Ghafourian A; Habibi A; Foroutan P; Ashrafkhorasani M; Alemzadeh SA
Indian J Ophthalmol; 2018 Apr; 66(4):578-580. PubMed ID: 29582827
[TBL] [Abstract][Full Text] [Related]
20. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis.
Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ
Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
